Back

The Seattle heart failure and proportional risk model for prediction of ICD benefit in non-ischemic cardiomyopathy: A posthoc analysis of the DANISH trial

27 May 2018 (09:15 - 09:30)
Organised by:
Congress Presentation Part of: Young Investigator Award: Clinical Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Soeren Lund Kristensen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

5 More presentations in this session

Presentation thumbnail
Incidence of dyskalemia in heart failure with preserved, mid-range, and reduced ejection fraction: an analysis of 6,401 patients from the swedish heart failure registry
Doctor G. Savarese (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Interplay between recipient age and comorbidities in heart transplant survival: a step towards a tailored approach for advanced heart failure therapies
Doctor M. Bellettini (Turin, IT)
Abstract Slides Video
Presentation thumbnail
Heart failure patients with a higher protein intake live longer
Mr K. Streng (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
High prevalence of cancer in patients with peripartum cardiomyopathy: is there a pathophysiological connection between these two entities?
Ms S. Schlothauer (Hannover, DE)
Abstract
Presentation thumbnail
Improving risk stratification for sudden cardiac death in dilated cardiomyopathy using late gadolinium enhancement cardiovascular magnetic resonance
Doctor B. Halliday (London, GB)
Abstract

Access the full session

Session thumbnail
Young Investigator Award: Clinical

The Event

Event poster

Heart Failure 2018

27 May 2018 09:15 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Arrhythmias and devices
thumbnail
Congress Session
When to consider device therapy in HFrEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources